Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP470645.RAW3wqx7G1v9OH5q4g9SiBtrJzMKUReWA_SI1ImgT0UhE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP470645.RAW3wqx7G1v9OH5q4g9SiBtrJzMKUReWA_SI1ImgT0UhE130_assertion type Assertion NP470645.RAW3wqx7G1v9OH5q4g9SiBtrJzMKUReWA_SI1ImgT0UhE130_head.
- NP470645.RAW3wqx7G1v9OH5q4g9SiBtrJzMKUReWA_SI1ImgT0UhE130_assertion description "[Genomic amplification of the MYCN oncogene has been used to predict outcome in neuroblastoma for over 30�years, however, recent methodological advances including miRNA and mRNA profiling, comparative genomic hybridization (array-CGH), and whole-genome sequencing have enabled the detailed analysis of the neuroblastoma genome, leading to the identification of new prognostic markers and better patient stratification.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP470645.RAW3wqx7G1v9OH5q4g9SiBtrJzMKUReWA_SI1ImgT0UhE130_provenance.
- NP470645.RAW3wqx7G1v9OH5q4g9SiBtrJzMKUReWA_SI1ImgT0UhE130_assertion evidence source_evidence_literature NP470645.RAW3wqx7G1v9OH5q4g9SiBtrJzMKUReWA_SI1ImgT0UhE130_provenance.
- NP470645.RAW3wqx7G1v9OH5q4g9SiBtrJzMKUReWA_SI1ImgT0UhE130_assertion SIO_000772 23274701 NP470645.RAW3wqx7G1v9OH5q4g9SiBtrJzMKUReWA_SI1ImgT0UhE130_provenance.
- NP470645.RAW3wqx7G1v9OH5q4g9SiBtrJzMKUReWA_SI1ImgT0UhE130_assertion wasDerivedFrom befree-20150227 NP470645.RAW3wqx7G1v9OH5q4g9SiBtrJzMKUReWA_SI1ImgT0UhE130_provenance.
- NP470645.RAW3wqx7G1v9OH5q4g9SiBtrJzMKUReWA_SI1ImgT0UhE130_assertion wasGeneratedBy ECO_0000203 NP470645.RAW3wqx7G1v9OH5q4g9SiBtrJzMKUReWA_SI1ImgT0UhE130_provenance.